COMMENTARY
Citation: White WB, Schnitzer TJ, Fleming R, Duquesroix B, Beekman M. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis. Am J Cardiol. 2009;104:840-845.
Medscape Cardiology © 2010
WebMD, LLC
Cite this: Henry R. Black. Naproxcinod -- Does This New Drug Mean That Safe Pain Relief Is at Hand? - Medscape - Feb 05, 2010.
 | Clinical Professor of Internal Medicine; Director of Hypertension Research, New York University School of Medicine, NYU Center for the Prevention of Cardiovascular Disease, New York, NY |
processing....
Clinical Practice Guidelines and Consensus Statements About Pain Management in Critically Ill End-of-life Patients
The 'Silver Lining' of the Opioid Crisis: More Pain Research
A 10-Year-Old Boy With Acute Postoperative Pain: A Rational Approach to Opioid Prescribing
Why 'Choosing Wisely' Won't Protect You in a Lawsuit
Complementary and Alternative Medicine Use by Dental Patients
Keeping Med-Mal Premiums Low; MICRA in the Courts?; More
Comments